Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same
View Patent ↗The invention is directed to formulations comprised of multiple dietary and endogenously made antioxidants and B-vitamins and the use of these formulations in preventing and treating coronary artery disease.
1. A formulation for treatment of coronary artery disease, said formulation consisting essentially of:
Total Dose/Day
Vitamin A (palmitate)
3,000-5,000
I.U.
Beta-carotene (from natural D. salina )
10-20
mg
Vitamin D-3 (cholecalciferol)
400-600
I.U.
Natural source Vitamin E
(d-alpha tocopherol)
50-400
I.U.
(d-alpha tocopheryl acid succinate)
100
I.U.
Buffered Vitamin C (calcium ascorbate)
100-4,000
mg
Thiamine mononitrate
2-10
mg
Riboflavin
2-20
mg
Niacinamide ascorbate
15-200
mg
d-calcium pantothenate
5-30
mg
Pyridoxine hydrochloride
2-10
mg
Cyanocobalamin
5-20
mcg
Folic Acid (Folacin)
400-1,200
mcg
D-Biotin
100-500
mcg
Selenium (l-seleno-methionine)
50-200
mcg
Chromium picolinate
50-200
mcg
Zinc Glycinate
10-30
mg
Calcium citrate
100-500
mg
Magnesium citrate
100-250
mg
Vitamin C
100-4,000
mg
d-α-tocopheryl succinate
50-400
IU
N-acetylcysteine
100-500
mg
Alpha-lipoic acid
15-100
mg
Coenzyme Q10
10-250
mg
Omega-3 fatty acid
1,000-2,000
mg
wherein said formulation is designed to treat said coronary artery disease.
2. A method for preparing a formulation for treatment of coronary heart disease, said method comprises admixing a formulation consisting essentially of:
Total Dose/Day
Vitamin A (palmitate)
3,000-5,000
I.U.
Beta-carotene (from natural D. salina )
10-20
mg
Vitamin D-3 (cholecalciferol)
400-600
I.U.
Natural source Vitamin E
(d-alpha tocopherol)
50-400
I.U.
(d-alpha tocopheryl acid succinate)
100
I.U.
Buffered Vitamin C (calcium ascorbate)
100-4,000
mg
Thiamine mononitrate
2-10
mg
Riboflavin
2-20
mg
Niacinamide ascorbate
15-200
mg
d-calcium pantothenate
5-30
mg
Pyridoxine hydrochloride
2-10
mg
Cyanocobalamin
5-20
mcg
Folic Acid (Folacin)
400-1,200
mcg
D-Biotin
100-500
mcg
Selenium (l-seleno-methionine)
50-200
mcg
Chromium picolinate
50-200
mcg
Zinc Glycinate
10-30
mg
Calcium citrate
100-500
mg
Magnesium citrate
100-250
mg
Vitamin C
100-4,000
mg
d-α-tocopheryl succinate
50-400
IU
N-acetylcysteine
100-500
mg
Alpha-lipoic acid
15-100
mg
Coenzyme Q10
10-250
mg
Omega-3 fatty acid
1,000-2,000
mg
wherein said formulation is designed to treat said coronary artery disease.
3. A method for manufacturing a formulation for treatment of coronary heart disease, said method comprises admixing a therapeutically effective amount of formulation consisting essentially of:
Total Dose/Day
Vitamin A (palmitate)
about 5,000
I.U.
Beta-carotene (from natural D. salina )
about 15
mg
Vitamin D-3 (cholecalciferol)
about 400
I.U.
Natural source Vitamin E
(d-alpha tocopherol)
about 100
I.U.
(d-alpha tocopheryl acid succinate)
about 100
I.U.
Buffered Vitamin C (calcium ascorbate)
about 500
mg
Thiamine mononitrate
about 4
mg
Riboflavin
about 5
mg
Niacinamide ascorbate
about 30
mg
d-calcium pantothenate
about 10
mg
Pyridoxine hydrochloride
about 5
mg
Cyanocobalamin
about 10
mcg
Folic Acid (Folacin)
about 800
mcg
D-Biotin
about 200
mcg
Selenium (l-seleno-methionine)
abut 100
mcg
Chromium picolinate
about 50
mcg
Zinc Glycinate
about 15
mg
Calcium citrate
about 250
mg
Magnesium citrate
about 125
mg
Vitamin C
about 1,000
mg
d-alpha-tocopheryl-succinate
about 200
I.U.
N-acetylcysteine
about 250
mg
Alpha-lipoic acid
about 30
mg
Coenzyme Q 10
about 30
mg
Omega-3 fatty acid
about 1,000
mg
wherein said formulation is designed to treat said coronary artery disease.
4. A method for manufacturing a formulation for treatment of coronary heart disease, said method comprises admixing a therapeutically effective amount of formulation consisting essentially of:
Total Dose/Day
Vitamin A (palmitate)
about 5,000
I.U.
Beta-carotene (from natural D. salina )
about 15
mg
Vitamin D-3 (cholecalciferol)
about 400
I.U.
Natural source Vitamin E
(d-alpha tocopherol)
about 100
I.U.
(d-alpha tocopheryl acid succinate)
about 100
I.U.
Buffered Vitamin C (calcium ascorbate)
about 500
mg
Thiamine mononitrate
about 4
mg
Riboflavin
about 5
mg
Niacinamide ascorbate
about 30
mg
d-calcium pantothenate
about 10
mg
Pyridoxine hydrochloride
about 5
mg
Cyanocobalamin
about 10
mcg
Folic Acid (Folacin)
about 800
mcg
D-Biotin
about 200
mcg
Selenium (l-seleno-methionine)
about 100
mcg
Chromium picolinate
about 50
mcg
Zinc Glycinate
about 15
mg
Calcium citrate
about 250
mg
Magnesium citrate
about 125
mg
Vitamin C
about 2,000
mg
d-alpha-tocopheryl-succinate
about 600
I.U.
N-acetylcysteine
about 500
mg
Alpha-lipoic acid
about 60
mg
Coenzyme Q 10
about 90
mg
Omega-3 fatty acid
about 2,000
mg
wherein said formulation is designed to treat said coronary artery disease.